NCT02172118View on ClinicalTrials.gov

BI 1744 CL in Patients With Severe Renal Impairment in Comparison to Subjects With Normal Renal Function

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

December 31, 2009

Conditions
Healthy
Interventions
DRUG

BI 1774 CL

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY